I. Meyer

Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.

High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation

Advances and Challenges of Liposome Assisted Drug Delivery

Echinocandin resistance

The global problem of antifungal resistance: prevalence, mechanisms, and management

Co-infections in people with COVID-19: a systematic review and meta-analysis

MALDI-TOF-Mass Spectrometry Applications in Clinical Microbiology

Clinical implications of globally emerging azole resistance in Aspergillus fumigatus

Invasive Candidiasis

Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

Worldwide emergence of resistance to antifungal drugs challenges human health and food security

Antimicrobial photodynamic therapy – what we know and what we don’t

Update on Tick-Borne Rickettsioses around the World: a Geographic Approach

Aspergillus PCR in Bronchoalveolar Lavage Fluid for the Diagnosis and Prognosis of Aspergillosis in Patients With Hematological and Non-hematological Conditions

Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole

Rapid Species Diagnosis for Invasive Candidiasis Using Mass Spectrometry

Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?

Rapid Emergence of Echinocandin Resistance during Candida kefyr Fungemia Treatment with Caspofungin